chitosan has been researched along with Leishmaniasis, Cutaneous in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Çetin Uyanikgil, EÖ; Gürbüz Çolak, N; Özbel, Y; Töz, S | 1 |
| Ajalli, N; Akhtar, S; Díez-Pascual, AM; Ibrahim, IM; Kiani, MH; Rahdar, A; Rauf, A; Sarwar, HS; Shahnaz, G; Shakeel, M | 1 |
| Batool, S; Dar, MJ; Din, FU; Khaleeq, N; Khan, GM; Kim, DW; Rabia, S | 1 |
| Cabral, FV; Pelegrino, MT; Ribeiro, MS; Seabra, AB | 1 |
| Alishahi, M; Asgari, Q; Barzegar, S; Caravan, D; Davani, F; Enjavi, Y; Esfandiari, F; Khorram, M; Zomorodian, K | 1 |
| Barbosa, H; Delgado, G; Gutiérrez, J; Pinzón, J; Vallejo, B | 1 |
| Espuelas, S; Fernández, C; Irache, JM; Moreno, E; Navarro-Blasco, I; Nguewa, PA; Palop, JA; Sanmartín, C; Schwartz, J | 1 |
| Conde, I; Espuelas, S; Font, M; Irache, JM; Larrea, E; Moreno, E; Sanmartín, C; Schwartz, J | 1 |
| Ahmadi, F; Bahrami, S; Esmaeilzadeh, S; Zarei, M | 1 |
| Alimohammadian, MH; Darabi, H; Hoseini, MH; Moradi, M; Rostami, A; Shahgoli, VK | 1 |
10 other study(ies) available for chitosan and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Female; Gels; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Polymers | 2022 |
Emulgel-loaded mannosylated thiolated chitosan-coated silver nanoparticles for the treatment of cutaneous leishmaniasis.
Topics: Chitosan; Drug Carriers; Humans; Leishmaniasis, Cutaneous; Metal Nanoparticles; Nanoparticles; Particle Size; Silver | 2023 |
Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; Chitosan; Disease Models, Animal; Drug Delivery Systems; Flow Cytometry; Humans; Leishmaniasis, Cutaneous; Macrophages; Mice; Nanogels; Nanoparticles; Polyethylene Glycols; Polyethyleneimine; Rats; Rifampin | 2020 |
Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; Chitosan; Leishmania; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Nanoparticles; Nitric Oxide; Parasitic Sensitivity Tests | 2021 |
Fabrication of amphotericin B-loaded electrospun core-shell nanofibers as a novel dressing for superficial mycoses and cutaneous leishmaniasis.
Topics: Amphotericin B; Bandages; Chitosan; Humans; Leishmaniasis, Cutaneous; Nanofibers | 2021 |
In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
Topics: Antiprotozoal Agents; Cell Line; Cell Survival; Chitosan; Cicatrix; Drug Carriers; Excipients; Fibroblasts; Humans; Immunomodulation; Interleukins; Lactic Acid; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects; Povidone; Wound Healing | 2013 |
Topical treatment of L. major infected BALB/c mice with a novel diselenide chitosan hydrogel formulation.
Topics: Administration, Topical; Aniline Compounds; Animals; Antiprotozoal Agents; Chitosan; Drug Carriers; Female; Hydrogels; Leishmania major; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Mice, Inbred BALB C; Organoselenium Compounds; Parasite Load; Skin; Skin Absorption; Swine | 2014 |
Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.
Topics: Administration, Topical; Animals; Antiparasitic Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Lecithins; Leishmania major; Leishmaniasis, Cutaneous; Mice, Inbred BALB C; Nanoparticles; Naphthoquinones; Skin | 2015 |
Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.
Topics: Animals; Antiprotozoal Agents; Chitosan; Female; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Treatment Outcome | 2015 |
Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
Topics: Adjuvants, Immunologic; Animals; Cell Proliferation; Chitin; Chitosan; Cytokines; Female; Immunotherapy; Interferon-gamma; Leishmania major; Leishmaniasis, Cutaneous; Lymph Nodes; Mice, Inbred BALB C; Parasite Load; Subcutaneous Absorption; Tumor Necrosis Factor-alpha | 2016 |